Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma

被引:27
|
作者
Schwartz, Rebecca M. [1 ,2 ,3 ]
Lieberman-Cribbin, Wil [2 ,3 ]
Wolf, Andrea [4 ]
Flores, Raja M. [4 ,5 ]
Taioli, Emanuela [2 ,3 ,4 ,5 ]
机构
[1] Hofstra Northwell Sch Med, Northwell Hlth Phys Partners, Dept Occupat Med Epidemiol & Prevent, Great Neck, NY USA
[2] Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA
[4] Icahn Sch Med, Mt Sinai Hlth Syst, Dept Thorac Surg, New York, NY 10029 USA
[5] Icahn Sch Med Mt Sinai, Tisch Canc Inst, One Gustave L Levy Pl,Box 1133, New York, NY 10029 USA
关键词
Outcomes; Functional measures; Cancer; Surgical approach; CANCER-DIRECTED SURGERY; RADICAL PLEURECTOMY; TREATMENT PATTERNS; SURVIVAL; EPIDEMIOLOGY; MANAGEMENT; EXPOSURE; TRIAL; SURVEILLANCE; CHEMOTHERAPY;
D O I
10.1186/s12885-018-5064-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundFew studies have focused on quality of life (QoL) after treatment of malignant pleural mesothelioma (MPM). There are still questions as to which surgical procedure, extrapleural pneumonectomy (EPP) or pleurectomy decortication (P/D) is most effective and results in better survival outcomes, involves fewer complications, and results in better QoL. Here we performed a literature review on MPM patients to assess and compare QoL changes after P/D and EPP.MethodsResearch articles concerning QoL after mesothelioma surgery were identified through May 2018 in Medline. For inclusion, studies were 1) cohort or randomized controlled trials (RCT)design, 2) included standardized QoL instruments, 3) reported QoL measurement after surgery, 4) described the type of surgery performed (EPP or P/D), 5) were written in English. Measures of lung function (FEV1, FVC) and measures from the EORTC-C30 were compared 6months following surgery with preoperative values.ResultsQoL data was extracted from 17 articles (14 datasets), encompassing 659 patients (102 EPP, 432 P/D); the available evidence was of low quality. While two studies directly compared QoL between the two surgical procedures, additional data was available from one arm of two RCTs, as the RCTs were not comparing EPP and P/D. The remaining data was reported from observational studies. While QoL was still compromised 6months following surgery, from the limited and low quality data available it would appear that P/D patients had better QoL than EPP patients across all measures. Physical function, social function and global health were better at follow-up for P/D than for EPP, while other indicators such as pain and cough were similar. Forced Expiratory Volume (FEV1) and Forced Vital Capacity (FVC) were reported in one study only, and were higher at follow-up for P/D compared to EPP.ConclusionsAlthough the existing evidence is limited and of low quality, it suggests that P/D patients have better QoL than EPP patients following surgery. QoL outcomes should be factored into the choice of surgical procedure for MPM patients, and the possible effects on lung function and QoL should be discussed with patients when presenting surgical treatment options.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Quantitation and predictors of short-term mortality following extrapleural pneumonectomy, pleurectomy/decortication, and nonoperative management for malignant pleural mesothelioma
    Wright, Christopher
    Verma, Vivek
    Barsky, Andrew R.
    Haque, Waqar
    Polamraju, Praveen V.
    Ludmir, Ethan B.
    Zaorsky, Nicholas G.
    Lehrer, Eric J.
    Trifiletti, Daniel M.
    Grover, Surbhi
    Friedberg, Joseph S.
    Simone, Charles B., II
    JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 6476 - 6493
  • [22] Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients - Discussion
    Sugarbaker, D.
    Flores
    Krasna, M.
    Weder, W.
    Bueno, R.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 135 (03): : 625 - 626
  • [23] Systematic review on pleurectomy/decortication in the multimodality treatment of malignant pleural mesothelioma
    Sestini, Stefano
    Bills, Andrea
    Okiror, Lawrence
    Gisabella, Mara
    Pastorino, Ugo
    LUNG CANCER MANAGEMENT, 2014, 3 (04) : 345 - 354
  • [24] Quality of Life After Radical Pleurectomy Decortication for Malignant Pleural Mesothelioma
    Mollberg, Nathan M.
    Vigneswaran, Yalini
    Kindler, Hedy L.
    Warnes, Cynthia
    Salgia, Ravi
    Husain, Aliyah N.
    Vigneswaran, Wickii T.
    ANNALS OF THORACIC SURGERY, 2012, 94 (04): : 1086 - 1093
  • [25] Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints
    Magouliotis, Dimitrios
    Tasiopoulou, Vasiliki
    Spiliopoulos, Kyriakos
    Svokos, Konstantina
    Svokos, Alexis
    Athanassiadi, Kalliopi
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [26] The effect of extrapleural pneumonectomy versus radical pleurectomy/decortication on the pattern of disease progression in epithelioid malignant pleural mesothelioma
    Nakas, Apostolos
    Begum, Shah Sheikh S.
    Martin-Ucar, Antonio E.
    Black, Edward
    Edwards, John G.
    Waller, David A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S321 - S321
  • [27] Current Treatment of Mesothelioma Extrapleural Pneumonectomy Versus Pleurectomy/Decortication
    Wolf, Andrea S.
    Flores, Raja M.
    THORACIC SURGERY CLINICS, 2016, 26 (03) : 359 - +
  • [28] Pleurectomy/decortication for malignant pleural mesothelioma
    Takuwa, Teruhisa
    Hasegawa, Seiki
    JOURNAL OF THORACIC DISEASE, 2017, 9 (03) : 460 - 461
  • [29] Extrapleural pneumonectomy and extended pleurectomy/decortication for malignant pleural mesothelioma: the Memorial Sloan-Kettering Cancer Center approach
    Rusch, Valerie W.
    ANNALS OF CARDIOTHORACIC SURGERY, 2012, 1 (04) : 523 - 531
  • [30] Do we still need to debate the merits of pleurectomy/decortication vs. extrapleural pneumonectomy for malignant pleural mesothelioma?
    Nakamura, Akifumi
    Kuribayashi, Kozo
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (02) : 193 - 196